via Nature
The number of drug-resistant tuberculosis (TB) cases is rising globally. But a newly discovered natural antibiotic — produced by bacteria from the lung infection in a cystic fibrosis patient — could help fight these infections.
Lab testing reported in the Journal of the American Chemical Society shows that the compound is active against multi-drug resistant strains.
Starting with the famous first discovery of penicillin from mold, scientists have continued to search for natural sources of antibiotics. And as pathogens develop resistance to once-reliable medicines, the search has taken on a new urgency. By 2040, more than a third of all TB cases in Russia, for example, could show resistance to first-line drugs currently used to fight the disease, a recent report published in Lancet estimates. Among potential new drug sources are species of the bacterial genus Burkholderia that thrive in a wide range of habitats, from soil to the human lung. One way these microbes have adapted to these diverse environments is by making potent antibiotics to take out their competition. In light of the growing threat of drug-resistant bacteria, particularly among TB strains, Gregory L. Challis, Eshwar Mahenthiralingam and colleagues wanted to see if Burkholderia might produce a promising anti-TB compound.
The researchers discovered that one species, Burkholderia gladioli, which was isolated from the sputum of a child with cystic fibrosis, produces an antibiotic called gladiolin. The compound belongs to the same structural class as etnangien, another antibiotic that has been investigated for its ability to jam bacterial cell machinery. But etnangien is highly unstable. The researchers found that gladiolin is much more stable than etnangien, and could therefore potentially be a better drug candidate. Lab testing also showed that gladiolin blocked the growth of four drug-resistant TB strains.
Learn more: Bacteria from cystic fibrosis patient could help thwart antibiotic-resistant TB
[osd_subscribe categories=’tuberculosis’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “TUBERCULOSIS”‘]
The Latest on: Antibiotic-resistant TB
[google_news title=”” keyword=”antibiotic-resistant TB” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Study shows FDA-approved TB regimen may not work against the deadliest form of TB due to multidrug-resistant strainson January 27, 2023 at 7:12 am
Findings from a Johns Hopkins Children's Center study in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) ...
- Global Mycobacterium Tuberculosis Treatment 2023: Emergence of New Treatment Regimen for Highly Drug-Resistant Forms of Tuberculosison January 25, 2023 at 9:40 pm
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast ...
- Zimbabwe: Communities Can Lead TB Fight From the Fronton January 25, 2023 at 4:37 am
Not only is TB dangerous for the infected individual, it is also dangerous for the community. Tuberculosis spreads through airborne droplet particles. These droplets can stay in the air for hours, ...
- Communities can lead TB fight from the fronton January 24, 2023 at 5:04 pm
In 2019, an estimated 1 200 diagnosed TB cases had drug resistant TB. Zimbabwe had an estimated TB incidence of 190 per every 100 000 population in 2020 The country has made gains in reducing the ...
- WHO to launch council to accelerate the development of TB vaccineon January 20, 2023 at 2:56 am
In 2021, about 10.6 million individuals contracted TB, 1.6 million of whom died. According to a recent report, every year, approximately 500,000 individuals develop drug-resistant TB globally ...
- WHO launches council to accelerate the development of TB vaccineon January 20, 2023 at 1:50 am
Recently, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), announced the creation of the TB Vaccine Accelerator Council at a high-level panel at a World ...
- With daily injections and two years of costly treatment, TB survivors look for a ray of lighton January 19, 2023 at 9:17 pm
The 1/4/6x24 (one, four, six by 2024) campaign calls for TB patients to have access to evidence-based, long-awaited, shorter, less toxic treatment. But without mass availability of drugs, can India ...
- WHO to establish tuberculosis vaccine accelerator councilon January 18, 2023 at 6:23 am
The figures show an estimated 10.6 million contracted TB in 2021, an increase of 4.5% from 2020, and 1.6 million people died from the disease. WHO also reported that the burden of drug-resistant TB ...
- Activists challenge patent extension to TB drug in Indiaon January 18, 2023 at 12:50 am
Two tuberculosis survivors from India and South Africa are challenging American pharmaceutical giant Johnson & Johnson’s extension of its patent on the drug bedaquiline through the Indian Patent ...
- WHO Announces Plans To Establish A TB Vaccine Accelerator Councilon January 17, 2023 at 5:27 pm
The adverse impact of the COVID-19 pandemic on tuberculosis (TB) services has brought the urgency of vaccine development effo ...
via Google News and Bing News
